Novavax, Inc. (NVAX)
8.22
+0.07
(+0.86%)
USD |
NASDAQ |
Apr 24, 16:00
8.26
+0.04
(+0.49%)
After-Hours: 05:02
Novavax Market Cap : 1.339B for April 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co., Inc. | 276.66B |
| Pfizer Inc. | 153.59B |
| Moderna, Inc. | 20.12B |
| Johnson & Johnson | 547.64B |
| Intellia Therapeutics, Inc. | 1.610B |
Market Cap Related Metrics
| PE Ratio | 3.453 |
| PS Ratio | 1.248 |
| Price | 8.22 |
| Earnings Yield | 28.96% |
| Operating PE Ratio | 2.489 |
| Normalized PE Ratio | 2.772 |